海外の治験の状況「1」での検索結果
148件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- A Phase III study to compare two drugs (called Cabotegravir and Rilpivirine, as oral tablets followed by long-acting injections) to current HIV regimens containing three drugs
- Human Immunodeficiency Virus type 1 (HIV-1) MedDRA version: 19.0 Level: LLT Classification code 10003582 Term: Asymptomatic human immunodeficiency virus type I infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Australia, Canada, France, Germany, Italy, Korea, Democratic People's Republic of, Mexico, Russian Federation, South Africa, Spain, Sweden, United States
- 2016-08-05
Authorised
- Phase 2 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLC
- First-line treatment of metastatic NSCLC MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-11-22
Authorised
- A study of Iclusig (ponatinib), an oral kinase-inhibitor treatment administered, by standard dose or reduced doses, for patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) who no longer benefit from, or who have an abnormal gene (T315I positive) marker for resistance to other kinase-inhibitor treatments.
- Chronic Phase Chronic Myeloid Leukemia MedDRA version: 20.0 Level: LLT Classification code 10054352 Term: Chronic phase chronic myeloid leukemia System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Argentina, Australia, Belgium, Canada, Chile, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Italy, Japan, Korea, Republic of, Netherlands, Norway, Poland, Portugal, Russian Federation, Singapore, Spain, Sweden, Taiwan, United Kingdom, United States
- 2015-07-07
Authorised
- An open study comparing the efficacy of S-1 and Cisplatin in combination versus 5-FU and Cisplatin in patients with Gastric cancer not previously treated with chemotherapy.
- Metastatic Diffuse Gastric Cancer MedDRA version: 17.0 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Belgium, Brazil, Bulgaria, Colombia, Croatia, Estonia, Germany, Hungary, Italy, Lithuania, Mexico, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom, United States
- 2010-12-03
Authorised
- A 34-week Follow-up to: A Study of Sitagliptin/Metformin in Pediatric Patients with Type 2 Diabetes Mellitus not Controlled on Metformin Therapy (Alone or in Combination with Insulin).
- Type 2 Diabetes Mellitus;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Argentina, Bulgaria, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Germany, Guatemala, India, Israel, Italy, Latvia, Lithuania, Malaysia, Mexico, New Zealand, Romania, Russian Federation, Saudi Arabia, Sri Lanka, Thailand, United Arab Emirates, United Kingdom, United States
- 2014-12-22
Authorised
- Study to collect data to further monitor whether the treatment triggers an immune reaction (i.e. development of antibodies, so called “inhibitors” directed against factor 8), to further investigate how well Human-cl rhFVIII prevents and stops bleeding episodes, and to monitor if it is safe and well tolerated in the treatment on a long-term basis.
- Severe Haemophilia A MedDRA version: 16.1 Level: LLT Classification code 10018938 Term: Haemophilia A (Factor VIII) System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Brazil, Canada, Colombia, France, Georgia, Germany, India, Moldova, Republic of, Morocco, Poland, Russian Federation, Spain, Ukraine, United Kingdom, United States, Venezuela, Bolivarian Republic of
- 2013-11-20
Authorised
- Comparative effectiveness of 1 month of ticagrelor plus aspirin followed by ticagrelor monotherapy versus a current-day intensive dual antiplatelet therapy in all-comers patients undergoing percutaneous coronary intervention with bivalirudin and BioMatrix family drug-eluting stent use.
- Subjects either male or female eligible for percutaneous coronary intervention (PCI) with lesions suitable for stent implantation who meet all eligibility criteria and provide written informed consent will be included. Of note, inclusion criteria will be kept comprehensive to reflect routine clinical practice (i.e. “real world, all-comers” patients). MedDRA version: 14.1 Level: PT Classification code 10011078 Term: Coronary artery disease System Organ Class: 10007541 - Cardiac disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Singapore, Spain, Sweden, Switzerland, United Kingdom
- 2013-03-28
Authorised
- Safety and Efficacy Study of Pegylated Interferon Lambda with and without Daclatasvir, compared to Pegylated Interferon Alfa, plus Ribavirin in Subjects with Hepatitis C Genotype 2 and 3
- Chronic Hepatitis C MedDRA version: 16.0 Level: PT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Finland, France, Greece, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Puerto Rico, Russian Federation, Singapore, Taiwan, United Kingdom, United States
- 2012-05-28
Authorised
- A study in people with type 2 diabetes to determine how well a meal-time insulin, LY900014, controls diabetes compared to Humalog (insulin lispro) when both are used along with a long-acting insulin
- Type II Diabetes Mellitus MedDRA version: 19.1 Level: LLT Classification code 10020639 Term: Hyperglycemia System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Argentina, Australia, Czech Republic, Germany, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Puerto Rico, Russian Federation, Slovakia, Spain, Taiwan, United States
- 2017-04-04
Authorised
- Phase 1/2 Study to Evaluate the Safety and Efficacy of BMN 250 in Patients with MPS IIIB
- Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B, MPS IIIB) MedDRA version: 20.0 Level: LLT Classification code 10056918 Term: Sanfilippo's syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 20.1 Level: PT Classification code 10056890 Term: Mucopolysaccharidosis III System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Australia, Colombia, Germany, Spain, Taiwan, Turkey, United Kingdom
- 2015-09-30
